This inventor holds 37 USPTO granted patents and 9 published patent applications and 20 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Medshine Discovery Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Zhuhai United Laboratories Co., Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nanjing, CN (2019)
- Wuhan, CN (2020)
- Dongguan, CN (2020)
- Shanghai, CN (2018 - 2024)
Company Filing History:
12 out of 72 
6 out of 121 
5 out of 8 Years Active: 2018-2026
Areas of Expertise:
Title: Guoping Hu: Pioneering Innovations in Pharmaceuticals
Introduction:
Guoping Hu, a visionary inventor hailing from Shanghai, China, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, his groundbreaking work has been at the forefront of advancements in the treatment of various diseases.
Latest Patents:
1. Compound for use in retinal diseases: Guoping's innovative compound, designed as an aldehyde binder, shows promise in the treatment of retinal diseases. This patent represents a significant step forward in addressing ocular health.
2. [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor: Another notable patent by Guoping Hu involves a JAK inhibitor compound, crucial for developing drugs to target diseases associated with JAK1 or TYK2. This patent underscores his commitment to advancing therapies for challenging conditions.
Career Highlights:
Guoping Hu has left an indelible mark on the pharmaceutical industry, with stints at renowned companies such as Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His expertise and dedication have propelled these organizations towards excellence in drug discovery and development.
Collaborations:
Throughout his illustrious career, Guoping has had the privilege of collaborating with esteemed professionals in the field. Noteworthy among his coworkers are Jian Li and Shuhui Chen, whose collective efforts have led to groundbreaking innovations in the pharmaceutical sector.
Conclusion:
In conclusion, Guoping Hu's inventive spirit and tireless pursuit of excellence have solidified his position as a trailblazer in pharmaceutical research. His patents and collaborations stand as testaments to his unwavering commitment to advancing healthcare solutions, particularly in the realm of cutting-edge drug development for challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile